Skip to main content
. 2022 Jun 21;10(6):e004409. doi: 10.1136/jitc-2021-004409

Table 1.

Overview of WT1 peptides included in this study

Nr Peptide HLA Sample/cell line source BMI
1 WTEGQSNHSTGY A*01:01 OVCA-G1, ALL-1833, AML-4443, AML-10197 43
2 VLDFAPPGASAY A*01:01 AML-4443 36
3 ALLPAVPSL A*02:01 OVCA-L23 31
4 VLDFAPPGA A*02:01 OVCA-L23 26
5 FGPPPPSQA A*02:01 OVCA-L23, AML-10197 42
6 AQFPNHSFK A*03:01 Cell line-COV362.4 20
7 HAAQFPNHSF B*35:01 HCL-4512 36
8 TPYSSDNLY B*35:01 ALL-2184 41
9 RMFPNAPYL A*02:01 x x
10 CMTWNQMNL A*02:01 x x
11 RWPSCQKKF A*24:02 x x
12 CMTWNQMNL A*24:02 x x

Overview of the 12 WT1 peptides included in this study. For the eight WT1 peptides identified in our HLA ligandome analyses, the source and best Mascot ion score (BMI) is listed. The four peptides not identified in this study, but previously described in literature, were added at the end of the table.

ALL, acute lymphoblastic leukemia; AML, acute myeloid leukemia; BMI, Best Mascot Ion; HCL, hairy cell leukemia; OVCA, primary ovarian carcinoma.